Management of prostate and bladder cancer in the elderly

Urologic Clinics of North America

Volumn 23, Issue 1, 1996, Pages 87-97

  Dreicer, R ^a   Cooper, C S ^a   Williams, R D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANDROGEN; ANTIANDROGEN; ANTINEOPLASTIC AGENT; BCG VACCINE; CARCINOGEN; CISPLATIN; DNA; DOXORUBICIN; HEMOGLOBIN; METHOTREXATE; MITOMYCIN C; PACLITAXEL; PROSTATE SPECIFIC ANTIGEN; THIOTEPA; VINBLASTINE;

AGED; BLADDER CANCER; BONE MARROW SUPPRESSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MALE; METASTASIS; MORBIDITY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURGICAL MORTALITY; SURGICAL TECHNIQUE;

EID: 0029997597     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70295-0     Document Type: Article

References (85)

1. V.N. Anisimov Carcinogenesis and Aging vol 1 1987 CRC Press Boca Raton, FL 1
2. L. Balducci K. Mowry Pharmacology and organ toxicity of chemotherapy in older patients Oncology 6 suppl 1992 62
3. J.R. Beck M.W. Kattan B.J. Miles A critique of the decision analysis for clinically localized prostate cancer J Urol 152 1994 1894
4. C.B. Begg P.P. Carbone Clinical trials and drug toxicity in the elderly: The experience of the Eastern Cooperative Oncology Group Cancer 52 1983 1986
5. M.C. Benson C.A. Olsson Urinary diversion Walsh P.C. Retik A.B. Stamey T.A. Vaughn E.D. Campbell's Urology ed 6 1992 WB Saunders Philadelphia 2654
6. N.K. Bissada R.R. Morcos W.M. Morgan Ureterosigmoidostomy: Is it a viable procedure in the age of continent urinary diversion and bladder reconstruction? J Urol 153 1995 1425
7. Bureau of the Census Current Population Reports. Special Studies. Sixty-five Plus in America 1993 Government Printing Office Washington, DC (P23–178RV)
8. W.J. Catalona Management of cancer of the prostate N Engl J Med 331 1994 996
9. W.J. Catalona Urothelial tumors of the urinary tract Walsh P.C. Retik A.B. Stamey T.A. Vaughn E.D. Campbell's Urology ed 6 1992 WB Saunders Philadelphia 1094
10. W.J. Catalona J.W. Basler Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy J Urol 150 1993 905
11. W.J. Catalona S.W. Bigg Nerve-sparing radical prostatectomy: Evaluation of results after 250 patients J Urol 143 1990 538
12. M.E. Charlson P. Pompei K.L. Ales A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation Journal of Chronic Diseases 40 1987 373
13. G.W. Chodak R.A. Thisted G.S. Gerber Results of conservative management of clinically localized prostate cancer N Engl J Med 330 1994 242
14. P.J. Coloby T. Kakizoe K.-I. Tobisu Urethral involvement in female bladder cancer patients: Mapping of 47 consecutive cysto-urethrectomy patients J Urol 153 1994 1438
15. E.D. Crawford M.A. Eisenberger D.G. McLeod A controlled trial of leuprolide with and without flutamide in prostatic carcinoma N Engl J Med 321 1989 419
16. I. Crocker L. Prosntiz Radiation therapy of the elderly Clin Geriatr Med 3 1987 473
17. W. D'Hoore C. Sicotte C. Tilquin Risk adjustment in outcome assessment: The Charlson comorbidity index Methods Inf Med 32 1993 382
18. R. Dreicer B. Roth K. Propert E5892 vinblastine, ifosfamide and gallium nitrate (VIG) in advanced carcinoma of the urothelium: A phase II trial of the Eastern Cooperative Oncology Group Proceedings of the American Society of Clinical Oncology 14 1995 659
19. T. Duckett R.B. Smith Postoperative problems O'Donnell P.D. Geriatric Urology 1994 Little, Brown & Co Boston 95
20. L. Einhorn Approaches to drug therapy in older cancer patients Oncology 6 suppl 1992 69
21. W.R. Fair Z.Y. Fuks H.I. Scher Cancer of the bladder DeVita V.T. Jr Hellman S. Rosenberg S.A. Cancer: Principles & Practice of Oncology ed 4 1993 JB Lipincott Philadelphia 1062
22. C. Fleming J.H. Wasson P.C. Albertsen A decision analysis of alternative treatment strategies for clinically localized prostate cancer JAMA 269 1993 2650
23. F.J. Fowler A. Roman M.J. Barry Patient-reported complications and follow-up treatment after radical prostatectomy. The national Medicare experience: 1988–1990 Urology 42 1993 622
24. H.A. Frazier J.E. Robertson D.F. Paulson Radical prostatectomy: The pros and cons of the perineal versus retropubic approach J Urol 147 1992 888
25. F.S. Freiha Open bladder surgery Walsh P.C. Retik A.B. Stamey T.A. Vaughn E.D. Campbell's Urology ed 6 1992 WB Saunders Philadelphia 2750
26. N.L. Geller C.N. Sternberg D. Penenberg Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy Cancer 67 1991 1525
27. Glascock JM, Winfield HN: Laparoscopic pelvic lymphadenectomy: Intra- and extraperitoneal access. In Smith AD, Badlani GH, Bagley DH, et al (eds): Smith's Textbook of Endourology. St. Louis, Quality Medical Publishing, in press
28. J.K. Gohagan P.C. Prorok B.S. Kramer The prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute Cancer 75 1995 1869
29. M.K. Gospodarowicz N.V. Hawkins G.A. Rawlings Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: Failure analysis J Urol 142 1989 1448
30. H. Grönberg J. Damber H. Jonsson Patient age as a prognostic factor in prostate cancer J Urol 152 1994 892
31. F. Haab L. Boccon-Gibod V. Delmas Perineal versus retropubic radical prostatectomy for T1, T2 prostate cancer J Urol 74 1994 626
32. G.E. Hanks B.W. Corn W.R. Lee External beam irradiation of prostate cancer: Conformal treatment techniques and outcomes for the 1990s Cancer 75 1995 1972
33. W.G. Harker F.J. Meyers F.S. Freiha Cisplatin methotrexate, and vinblastine (CMV): An effective chemotherapy regimen for metastatic transitional cell carcinoma of the urothelial tract: A Northern California Oncology Group study J Clin Oncol 3 1985 1463
34. L. Harlan O. Brawley F. Pommerenke Geographic, age and racial variation in the treatment of local/regional carcinoma of the prostate J Clin Oncol 13 1995 93
35. R.E. Hautmann T.W. Sauter U.K. Wenderoth Radical retropubic prostatectomy: Morbidity and urinary continence in 418 consecutive cases Urology 43 suppl 2 1994 47
36. H.W. Herr Conservative management of muscle-infiltrating bladder cancer: Prospective experience J Urol 138 1987 1162
37. S. Johnson J. Pederson Cystectomy and urinary diversion during twenty years-complications and metabolic implications Eur Urol 24 1993 343
38. D.W. Keetch C.G. Klutke W.J. Catalona Late decompensation of neobladder J Urol 148 1992 806
39. C.A. Lawton M. Won M.V. Pilepich Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706 Int J Radiat Oncol Biol Phys 21 1991 935
40. P. Leandri G. Rossignol J.R. Gautier Radical retropubic prostatectomy: Morbidity and quality of life. Experience with 620 consecutive cases J Urol 147 1992 883
41. S.E. Litwiller B. Djavan B.V. Klopukh Radical retropubic prostatectomy for localized carcinoma of the prostate in a large metropolitan hospital: Changing trends over a 10-year period (1984–1994) Urology 45 1995 813
42. G.L. Lu-Yao D. McLerran J. Wasson An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes JAMA 269 1993 2633
43. D.H. Mark Mortality of patients after radical prostatectomy: Analysis of recent Medicare claims J Urol 152 1994 896
44. W.J. Merrell Anesthetic considerations O'Donnell P.D. Geriatric Urology 1994 Little, Brown & Co Boston 61
45. C. Mettlin G.W. Jones G.P. Murphy Trends in prostate cancer in the United States, 1974–1990: Observations from the patient care evaluation studies of the American College of Surgeons Commission in Cancer CA Cancer J Clin 43 1993 83
46. G.P. Murphy C. Mettlin H. Menck National patterns of prostate cancer treatment by radical prostatectomy: Results of a survey by the American College of Surgeons Commission on Cancer J Urol 152 1994 1817
47. C.A. Olsson Management of invasive carcinoma of the bladder deKernion J.B. Paulson D.F. Genitourinary Cancer Management 1987 Lea & Febiger Philadelphia 65
48. R.O. Parra J.A. Boullier J.A. Ranscher The value of laparoscopic lymphadenectomy in conjunction with radical perineal or retropubic prostatectomy J Urol 151 1994 1599
49. R.O. Parra J.M. Cummings J.A. Boullier Technique of radical perineal prostatectomy Surgical Rounds 4 1995 131
50. D.F. Paulson J.W. Moul P.J. Walther Radical prostatectomy for clinical stage T1–2N0M0 prostatic adenocarcinoma: Long-term results J Urol 144 1990 1180
51. C.K. Payne J.W. Babiarz S. Raz Genitourinary problems in the elderly patient Surg Clin North Am 74 1994 401
52. 3): Review of management with external beam radiation therapy Cancer 72 1993 3156
53. C.A. Perez H.K. Lee A. Georgiou Technical factors affecting morbidity in definitive irradiation for localized carcinoma of the prostate Int J Radiat Oncol Biol Phys 26 1993 581
54. J.E. Phister S.G. Sue B.J. Cusack Problems in the use of anticancer drugs in the elderly Drugs 37 1989 551
55. P. Pompei Preoperative evaluation O'Donnell P.D. Geriatric Urology 1994 Little, Brown & Co Boston 49
56. G.R. Prout Jr P.P. Griffin W.U. Shipley Bladder carcinoma as a systemic disease Cancer 43 1979 2532
57. D.M. Quinlan J.I. Epstein B.S. Carter Sexual function following radical prostatectomy: Influence of preservation of neurovascular bundles J Urol 145 1991 998
58. D. Raghavan Chemotherapy for bladder cancer in the elderly Drugs Aging 3 1993 1
59. D. Raghavan R. Grundy T.M. Greenway Preemptive (neoadjuvant) chemotherapy prior to radical radiotherapy for fit septuagenarians with bladder cancer: Age itself is not a contra-indication Br J Urol 62 1988 154
60. J. Ramon P. Leandri G. Rossignol Urinary continence following radical retroperineal prostatectomy Br J Urol 71 1993 47
61. W.G. Reiner P.C. Walsh An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery J Urol 121 1979 198
62. M.I. Resnick R.M. Palmer Surgical decisions O'Donnell P.D. Geriatric Urology 1994 Little, Brown & Co Boston 13
63. B.J. Roth D.F. Bajorin Advanced bladder cancer: The need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) world J Urol 153 1995 894
64. E.K. Rowinsky R.C. Donehower The clinical pharmacology of taxol Semin Oncol 20 1993 16
65. R.K. Severson J.E. Montie A.T. Porter Recent trends in incidence and treatment of prostate cancer among elderly men J Natl Cancer Inst 87 1995 532
66. 2 tumor J Urol 152 1994 1799
67. D.G. Skinner Current perspectives in the management of high grade invasive bladder cancer Cancer 45 1980 1866
68. E.C. Skinner D.G. Skinner Management of bladder cancer O'Donnell P.D. Geriatric Urology 1994 Little, Brown & Co Boston 157
69. K.M. Slawin M. Ohori O. Dillioglugil Screening for prostate cancer: An analysis of the early experience CA Cancer J Clin 45 1995 134
70. M.S. Steiner R.A. Morton P.C. Walsh Impact of anatomical radical prostatectomy on urinary continence J Urol 145 1991 512
71. A. Stenzl H. Draxl B. Posch The risk of urethral tumors in female bladder cancer: Can the urethra be used for orthotopic reconstruction of the lower urinary tract? J Urol 153 1995 950
72. C.N. Sternberg A. Yagoda H.I. Scher M-VAC for advanced transitional cell carcinoma of the urothelium: Efficacy, and patterns of response and relapse Cancer 64 1989 2448
73. C.N. Sternberg A. Yagoda H.I. Scher Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for transitional cell carcinoma of the urothelium J Urol 133 1985 403
74. J.M.H. Teichman P.K. Reddy J.C. Hulbert Laparoscopic pelvic lymph node dissection, laparoscopically assisted seminal vesicle mobilization, and total perineal prostatectomy versus radical retropubic prostatectomy for prostate cancer Urology 45 1995 823
75. R. Thomas R. Steele R. Smith One-stage laparoscopic pelvic lymphadenectomy and radical perineal prostatectomy J Urol 152 1994 1174
76. S. Vijayakumar A. Awan T. Karrison Acute toxicity during external-beam radiotherapy for localized prostate cancer: Comparison of different techniques Int J Radiat Oncol Biol Phys 25 1993 359
77. P.C. Walsh The natural history of localized prostate cancer: A guide to therapy Walsh P.C. Retik A.B. Stamey T.A. Vaughn E.D. Jr Campbell's Urology ed 6 1995 WB Saunders Philadelphia Update No. 13
78. P.C. Walsh Radical prostatectomy: A procedure in evolution Semin Oncol 21 1994 662
79. P.C. Walsh J.I. Epstein F.C. Lowa Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle J Urol 138 1987 823
80. J.H. Wasson C.C. Cushman R.C. Bruskewitz A structured literature review of treatment for localized prostate cancer Archives of Family Medicine 2 1993 487
81. V.E. Weldon F.R. Tavel Potency-sparing racical perineal prostatectomy: Anatomy, surgical technique and initial results J Urol 140 1988 559
82. T.J. Wilt M.K. Brawer The prostate cancer intervention versus observation trial (PIVOT) Cancer 75 1995 1963
83. P.A. Wingo T. Tong S. Bolden Cancer statistics, 1995 CA Cancer J Clin 45 1995 8
84. D.P. Wood J.E. Montie T.J. Maatman Radical cystectomy for carcinoma of the bladder in the elderly patient J Urol 138 1987 46
85. H. Zincke E.J. Bergstralh M.L. Blute Radical prostatectomy for clinically localized prostate cancer: Long-term results of 1,143 patients from a single institution J Clin Oncol 12 1994 2254